返回
Designing and Evaluating an Autoverification RCV-Based System for Thyroid Function Profiles
DOI:10.3390/diagnostics16030407.png)
摘要
En 中文
Background/Objectives: Autoverification systems integrated with fully automated analyzers and expert middleware can reduce manual review workload and improve turnaround time (TAT). This study aimed to develop an autoverification system for thyroid function profiles and to evaluate its performance in clinical practice. Methods: A total of 1,219,141 routine thyroid function test results collected from 1 January 2016 to 31 December 2020 were used to design the autoverification system. The system incorporated quality control checks, instrument error flags, limit range rules, delta check rules, and logical rules. Validation was performed using an independent dataset comprising 81,713 test results. Results: Twelve instrument error flags, a two-step delta check algorithm, one set of limit range rules, and ten logical rules were established. The overall autoverification pass rate was 75.2%. After system optimization, the overall pass rate increased to 77.8%, and the median laboratory TAT decreased from 122.1 min to 88.6 min. Conclusions: The autoverification system for thyroid function profiles significantly improved laboratory efficiency and reduced TAT. While RCV-based delta checks require prior results and are therefore not applicable to new patients, other autoverification rules remain active, and only results that cannot be autoverified are routed to manual review, ensuring safe and complete result verification. This system provides a practical framework for implementing autoverification in routine clinical chemistry testing.
Keyword:
autoverification
thyroid hormones
reference change value
turnaround time (TAT)
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.3
论文数:
2.0W
被引数:
3.6W
机构
引用论文
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
THYROID
IF6.7
Impact of reference change value (RCV) based autoverification on turnaround time and physician satisfaction
BIOCHEMIA MEDICA
IF1.8
Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China长期全民食盐加碘治疗甲状腺疾病的有效性和安全性: 来自中国大陆31个省份的流行病学证据
THYROID
IF6.7

